Study objective: The objective was to determine whether external chest wall oscillation (ECWO) during sleep (1) reduced spontaneous ventilation while maintaining adequate gas exchange over several hours, (2) influenced the quality and distribution of sleep, and (3) 
breaths-min-1), an increase in apneas anid hypopneas attributable to upper airway obstiruction has been observed.'12'3 The precise mechanism and site of this upper airvay obstruction have not been clearly defined but are likely to relate at least in part to the amount of negative pressure applied. In healthy volunteers, airway collapse occurred when a threshold pressure of -12 cm H20 was superimposed on spontaneous breathing.14 Conventional negative pressure ventilators utilize pressures well in excess of this threshold.
In contrast, external chest wall oscillation (ECWO) involves oscillating the chest wall at higher than conventional frequencies using negative and positive pressures within a cuirass. Recent reports have suggested that ECWO can provide effective ventilation among healthy adults 15"6 and patients with COPD17 in the presence or absence of spontaneous breathing. In Clinical Investigations these studies, ECWO was effective and well tolerated at oscillatory frequencies of less than 2 Hz.
The external chest wall oscillator differs from a conventional negative pressure ventilator in that it achieves mechanical ventilatory support with less negative pressure. It is therefore possible that ECWO may not be associated with an increase in obstructive apneas and hypopneas. An alternative hypothesis is that even with a high operating frequency, a low chamber pressure span, and a positive expiratory assist, ECWO would still be associated with an increase in the apnea+hypopnea index because any airway exposure to negative pressure in the absence of spontaneous breathing will be associated with a predisposition to obstructive respiratory events.
Most reports have described the use of continuous ECWO for only brief periods, usually less than 1 h, although preliminary clinical information has suggested that it may be tolerated for much longer. 18"19 As it is both effective and easy to apply, ECWO may provide a practical noninvasive means of mechanical support for patients in whom a high ventilatory demand, altered mechanical load, or compromised respiratory muscle function contributes to ventilatory failure.1517 '20 Clearly, for those in whom ongoing support will be required for several hours or days, it is important to determine whether ECWO will be effective and well tolerated for longer periods.
The purpose ofthis study was to determine whether ECWO could be tolerated during sleep, whether adequate gas exchange could be maintained over several hours in the presence of a reduction in spontaneous ventilation, and whether subjects would develop an increase in the apnea+hypopnea index during sleep.
MATERIALS AND METHODS

Subjects
The protocol was approved by the University's Human Subjects Review Committee and the Hospital's Medical Advisory Committee. All participating subjects consented to the study after the procedures and risks had been explained to them. The subjects were not taking any medication and did not consume alcohol or caffeine on the evening of a sleep study.
External Chest Wall Oscillation
External chest wall oscillation was applied using an oscillator (Hayek Oscillator On nights without ECWVO, an obstructive apnea was defined as cessation of airflow despite respiratory effort as shown by the inductance plethysmograph. WVIhen no such effort was evident, apneas were considered to be of central origin. Mixed apneas contained periods of both central and obstructive apneas. During ECWO, all apneas were considered obstructive since pressure changes, "efforts," were constantly induced by the oscillator.
Protocol
During the introductory session, the negative pressure was adjusted so that eucapnia could be maintained during wakefulness with at least a 50% reduction in spontaneous VE. Adequacy of ECWO was determined by the following: (1) subject comfort; (2) stable normal SaO2 (>90%); (3) stable normal Pco2 (equal to or no more than 5 mm Hg less than resting Pco2); and (4) a reduction ('-50%) in spontaneous VE. The expiratory cuirass pressure wvas in the range of +1 to +10 cm H20 and the I:E was 1:1. Every subject completed 3 sleep studies, each separated by at least 1 week. The first sleep study was the control night. During the second sleep study, the subject either slept while wearing the cui- rass but breathing spontaneously or the subject received ECWO at settings previously determined. The third sleep study, at least 1 week later, wvas the remaining condition. The order of presentation of ECWO vas counterbalanced betveen subjects,25 ie, three subjects had ECWVO during the second night and four subjects had ECWNO during the third sleep night. Duiing the second and third nights, the cuirass limited the subjects to sleeping in a supine position.
Analysis
For each dependent variable, a one-way repeated measures analysis of variance was used to determine if there were significant differences amongthe treatment nights (control, cuirass, and ECVO). If so, a Student-Newman-Keuls test was used for multiple pairwise comparisons of the treatment nights for each dependent variable. A p<0.05 was considered significant for all statistical tests. All values were expressed as mean (SEM) unless stated otherwise.
RESULTS
Subjects
Seven healthy volunteers between the ages of29 and (213 [17] min) as compared with the control night (312 [19] During ECWO, 18 of 30 respiratory events were associated with an arousal whereas only 2 events were associated with an arousal on the control night. During the control night, the minimum SaO2 associated with apneas or hypopneas was 94% for the group and during the cuirass night the minimum SaO2 for the group was 92 to 94%. During ECWO, the minimum SaO2 was 85% with 4 of 6 subjects having an SaO2 of less than 90% during at least 1 event. The 1 subject with an elevated AHindex during the control night reached a nadir in SaO2 of 66% during ECWO. In other stages of sleep, the minimum SaO2 associated with apneas or hypopneas was greater than 90%.
DIsCUSSION
In healthy volunteers, ECWO provided adequate gas exchange in the presence of a reduction in spontaneous ventilation over several hours and therefore can be considered among the options for noninvasive ventilatory support. However, it was also associated with a reduction in the total sleep time and an increase in the number of apneas and hypopneas when compared with control measures.
The reduction in sleep quality might well have been modified had the subjects had more exposure to the oscillator. For most subjects, it was only their second experience with ECWO and the first during which the intent was to sleep. Neither the sensation ofthe cuirass on the chest wall nor the obligation to sleep in a supine position resulted in a sleep profile that differed from control (unencumbered) measures.
ECWO was well tolerated by the subjects and a substantial amount of sleep was achieved. The reduction in REM sleep (two of seven subjects did not achieve REM sleep) and the trend toward increased wakefulness and decreased sleep efficiency were small. Furthermore, ECWO compared well with more conventional negative pressure ventilation which induced a 20% reduction in sleep efficiency among 5 healthy subjects.'2 The absence of changes in the other indicators of sleep quality such as movement arousals, stage changes, and the amount of slow-wave sleep suggested that subjects could easily become accustomed to ECWO.
Whereas the inductance plethysmograph has been well validated among spontaneously breathing subjects, it was important to ensure valid measures of spontaneous ventilation in the setting of ECWO. This was achieved by low-pass filtering of any oscillations attributable to ECWO (Fig 1) and confirmed by calibrating with a rolling-seal spirometer both with and without ECWO at the beginning and at the end ofeach night. Negative pressure ventilation may have increased the functional residual capacity;26 therefore, we calibrated the inductance plethysmograph over a wide (3 L) volume. A mean chamber pressure of -2.5 cm H20 applied to a respiratory system with normal compliance was unlikely to have resulted in changes in volume outside the range of calibration. The good agreement (±50 mL) between the calibrated plethysmograph volume and the spirometer volume was also helped by maintaining a supine posture throughout the night.
Negative pressure ventilation at conventional frequencies has been associated with an increase in the number of apneas and hypopneas during sleep.'2 Although ECWO at 1 Hz did not avoid an increase in the AHindex, the increase in apneas and hypopneas during ECWO occurred predominantly during stage 2 sleep and individual responses were quite varied. Contrary to previous findings with negative pressure ventilation,12 subjects did not experience respiratory events during stage 4 sleep with ECWO. Furthermore, the one subject who experienced respiratory events during REM sleep had a relatively high AHindex during REM sleep on the control night. The predisposition to an increase in apneas and hypopneas during ECWO in subjects with an elevated AHindex (in the absence ofECWO) requires further assessment. These concerns are especially important if ECWO is used among individuals who may be predisposed to upper airway obstruction.
The clinical relevance of apneas and hypopneas likely depends on their association with sleep fragmentation or hypoxemia. Whereas on the control night 2 respiratory events were associated with an arousal, this increased to 18 with ECWO. The mean value for the minimum SaO2 was less than 90% during ECWO with the subject with the highest AHindex during the control night reaching a nadir of66% SaO2 during ECWO.
A similar case was reported'2 during negative pressure ventilation at a lower frequency. Although the clinical implications of arousals of this frequency and desaturations of this magnitude are unclear, subjects should be monitored overnight when ECWO is first used. During wakefulness, subjects may actively entrain their breathing with ECWO. Evidence of this entrainment was suggested by the substantial decreases in Pco2 during wakefulness even when the pressure oscillation was very modest. Furthermore, this entrainment persisted despite a Pco2 less than the apneic threshold. 27 The persistence of respiratory activity during assisted ventilation despite hypocapnia has been observed previously.28 30 We speculate that hypocapnia during wakefulness CHEST / 110/I / JULY, 1996 133 influenced the increase in the AHindex during the lighter stages of sleep. With the onset of sleep, as the cortical influence was lost, entrainment ceased at a time when the Pco2 was below the apneic threshold.27 At this time, the absence of upper airway dilator muscle activity3l rendered the subjects more susceptible to airway obstruction during ECWO. Although spontaneous ventilation associated with an arousal from sleep terminated the obstruction, the subjects once awake were predisposed to resume the entrainment and repeat this cycle of events. In retrospect, among our subjects, the lowest mean Pco2 during sleep immediately preceding wakefulness (40 [2] mm Hg) was significantly greater than the lowest mean Pco2 during wakefulness (35 [2] mm Hg). The increase in hypopneas was unlikely to have been attributable to sleeping in a supine position as the index was similar between the control and the cuirassonly nights. Nevertheless, modifications to the cuirass that would allow subjects to sleep on their side could increase subject comfort and thereby their tolerance for prolonged use of the equipment.
An attractive feature of the ECWO system is its ability to impose an oscillatory profile on a baseline negative chamber pressure. This has been observed to increase the operational lung volume,26 which could benefit some patients. However, the upper airway is also exposed to the subatmospheric pressure generated within the thorax. This has the potential of narrowing the upper airway, thereby increasing its resistance. The increase in airway resistance would necessitate more negative ventilating pressures and predispose the subject to airway obstruction during sleep. In healthy volunteers, a static pressure of -16 cm H20 superimposed on spontaneous inspiration induced upper airway collapse.14 Although the mean (-2.5 cm H20) and nadir (-11.1 cm H20) of the cuirass pressures experienced by our subjects did not approach this level, the negative intrathoracic pressures in the presence of attenuated upper airway dilator muscle activity might still have contributed to a reduction in airway caliber.
Negative airway transmural pressure also has a dynamic component that is dependent on the airflow. Upper airway closure occurred in healthy volunteers exposed to an additional brief (200 ms) transthoracic pressure of -12 cm H20 during spontaneous inspiration.14 Although we used ventilating pressures that ranged from -8.8 to -14.3 cm H20, the time to the nadir of pressure during ECWO was 500 ms. The mean and peak flows during ECWO were, therefore, lower so that this potential complication was likely avoided. Had it been present, respiratory events would have been observed in all sleep stages. In fact, the respiratory events were predominantly in stages 1 and 2 with few apneas or hypopneas in stages 3, 4, or REM sleep. By further increasing the inspiratory time, the same oscillatory tidal volume could be achieved at even lower transmural pressures. However, the mean and peak expiratory flows would then increase. This would promote dynamic hyperinflation and increase intrinsic positive end-expiratory pressure, especially in the presence of small airways disease.
It is remarkable that clinicians continue to evaluate the effectiveness ofnegative pressure ventilation in the treatment of patients with acute and chronic respiratory failure despite the availability of noninvasive positive pressure ventilators that would appear to be simpler to use. Although upper airway obstruction is less likely to occur with positive pressure ventilation, negative pressure ventilation clearly remains a viable alternative for those in whom tolerance of positive pressure ventilation is limited by discomfort with the face mask or nasal pillows, or the presence of gastric distention.
During wakefulness, both ECWO at 1 to 2 Hz and negative pressure ventilation at conventional frequencies can support gas exchange for short periods in the absence of spontaneous ventilation. One might speculate that the difficulty in synchronizing spontaneous breathing with negative pressure ventilation at conventional frequencies contributed to the poor subject tolerance of negative pressure ventilation.'1 At 1 Hz, subjects were not required to synchronize their breathing with the oscillator. A comparison between these two modalities of ventilatory support is necessary to establish whether the higher frequency and lower mean chamber pressure associated with ECWO accounted for the relatively good subject tolerance during sleep that we observed.
In conclusion, in healthy volunteers, ECWO maintained gas exchange for prolonged periods while allowing sleep. The quality of sleep was reduced in comparison to a control night and a night during which only the cuirass was used. It is possible that these effects might be attenuated with repeated exposure. ECWO was associated with an increase in the AHindex among healthy subjects and a substantial increase in one subject in whom the control AHindex was elevated. When ECWO is used for prolonged periods, it should be monitored at least initially during sleep.
